{"id":1068040,"date":"2021-01-27T14:55:27","date_gmt":"2021-01-27T19:55:27","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/mydecine-innovations-group-files-application-to-list-to-the-nasdaq\/"},"modified":"2024-08-18T11:42:13","modified_gmt":"2024-08-18T15:42:13","slug":"mydecine-innovations-group-files-application-to-list-to-the-nasdaq","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/mydecine-innovations-group-files-application-to-list-to-the-nasdaq.php","title":{"rendered":"Mydecine Innovations Group Files Application to list to the NASDAQ"},"content":{"rendered":"<p><![CDATA[DENVER, Jan.  27, 2021  (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (\u201cMydecine\u201d or the \u201cCompany\u2019), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, announced that it has submitted a formal application to list its common shares (\u201cShares\u201d) on the NASDAQ Stock Exchange (\u201cNASDAQ\u201d). NASDAQ is the second largest exchange by market capitalization worldwide and is home to many of the world\u2019s best technology companies.]]><\/p>\n<p>Original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2021\/01\/27\/2164968\/0\/en\/Mydecine-Innovations-Group-Files-Application-to-list-to-the-NASDAQ.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Mydecine Innovations Group Files Application to list to the NASDAQ\">Mydecine Innovations Group Files Application to list to the NASDAQ<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Original post: Mydecine Innovations Group Files Application to list to the NASDAQ <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/mydecine-innovations-group-files-application-to-list-to-the-nasdaq.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068040","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068040"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068040"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068040\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}